BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Treatment
22 results:

  • 1. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.
    Zeng S; Chen XI; Yi Q; Thakur A; Yang H; Yan Y; Liu S
    Oncol Res; 2023; 32(2):261-272. PubMed ID: 38186580
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cutaneous Melanoma and Hormones: Focus on Sex Differences and the Testis.
    Cosci I; Grande G; Di Nisio A; Rocca MS; Del Fiore P; Benna C; Mocellin S; Ferlin A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614041
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies.
    Giampietri C; Scatozza F; Crecca E; Vigiano Benedetti V; Natali PG; Facchiano A
    J Transl Med; 2022 Oct; 20(1):467. PubMed ID: 36224560
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Protective effects of tadalafil against cisplatin-induced spermatogenic dysfunction.
    Kaku Y; Chiba K; Sato K; Onishi A; Ishida T; Okada K; Fujisawa M
    Biochem Biophys Res Commun; 2022 May; 603():123-129. PubMed ID: 35287053
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pan-cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study.
    Sanborn RE; Hamid O; de Vries EG; Ott PA; Garcia-Corbacho J; Boni V; Bendell J; Autio KA; Cho DC; Plummer R; Stroh M; Lu L; Thistlethwaite F
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301808
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.
    Ashkar R; Feldman DR; Adra N; Zaid MA; Funt SA; Althouse SK; Perkins SM; Snow CI; Lazzara KM; Sego LM; Quinn DI; Hanna NH; Einhorn LH; Albany C
    Invest New Drugs; 2021 Dec; 39(6):1656-1663. PubMed ID: 34031784
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Is low-level metal exposure related to testicular cancer?
    Tariba Lovaković B; Živković Semren T; Safner T; Gamulin M; Soče M; Pizent A
    J Environ Sci Health C Toxicol Carcinog; 2021; 39(1):87-107. PubMed ID: 33576713
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immune checkpoints and their inhibitors: Reappraisal of a novel diagnostic and therapeutic dimension in the urologic malignancies.
    Sardana R; Mishra SK; Williamson SR; Mohanty A; Mohanty SK
    Semin Oncol; 2020 Dec; 47(6):367-379. PubMed ID: 33160642
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis.
    Dubey D; Wilson MR; Clarkson B; Giannini C; Gandhi M; Cheville J; Lennon VA; Eggers S; Devine MF; Mandel-Brehm C; Kryzer T; Hinson SR; Khazaie K; Hales C; Kattah J; Pavelko KD; Andrews P; Eaton JE; Jitprapaikulsan J; Mills JR; Flanagan EP; Zekeridou A; Leibovich B; Fryer J; Torre M; Kaufman C; Thoreson JB; Sagen J; Linnoila JJ; DeRisi JL; Howe CL; McKeon A; Pittock SJ
    JAMA Neurol; 2020 Nov; 77(11):1420-1429. PubMed ID: 32744608
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The immunotherapy revolution in genitourinary malignancies.
    U Gandhy S; Madan RA; Aragon-Ching JB
    Immunotherapy; 2020 Aug; 12(11):819-831. PubMed ID: 32594815
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
    Sharman JP; Wheler JJ; Einhorn L; Dowlati A; Shapiro GI; Hilton J; Burke JM; Siddiqi T; Whiting N; Jalal SI
    Invest New Drugs; 2019 Aug; 37(4):738-747. PubMed ID: 30993587
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Interaction of anti-cancer drug-cisplatin with major proteinase inhibitor-alpha-2-macroglobulin: Biophysical and thermodynamic analysis.
    Zia MK; Siddiqui T; Ali SS; Ahsan H; Khan FH
    Int J Biol Macromol; 2018 Sep; 116():721-727. PubMed ID: 29751037
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunotherapy advances in uro-genital malignancies.
    Ratta R; Zappasodi R; Raggi D; Grassi P; Verzoni E; Necchi A; Di Nicola M; Salvioni R; de Braud F; Procopio G
    Crit Rev Oncol Hematol; 2016 Sep; 105():52-64. PubMed ID: 27372200
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: an Izmir Oncology Group (IZOG) study.
    Salman T; Yildiz E; Yildiz I; Yavuzer D; Unlu M; Varol U; Akyol M; Yildiz Y; Bayoglu V; Kucukzeybek Y; Alacacioglu A
    J BUON; 2015; 20(4):1054-60. PubMed ID: 26416056
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The New Molecular Landscape of Cushing's Disease.
    Sbiera S; Deutschbein T; Weigand I; Reincke M; Fassnacht M; Allolio B
    Trends Endocrinol Metab; 2015 Oct; 26(10):573-583. PubMed ID: 26412158
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database.
    Oing C; Lorch A; Bokemeyer C; Honecker F; Beyer J; Berger LA; Oechsle K
    J Cancer Res Clin Oncol; 2015 May; 141(5):923-31. PubMed ID: 25395217
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German testicular cancer Study Group (GTCSG).
    Berger LA; Bokemeyer C; Lorch A; Hentrich M; Kopp HG; Gauler TC; Beyer J; de Wit M; Mayer F; Boehlke I; Oing C; Honecker F; Oechsle K
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1211-20. PubMed ID: 24696231
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report.
    Autorino R; Lamendola MG; De Sio M; Di Trolio RA; Ferraraccio F; Di Lorenzo G
    Int J Immunopathol Pharmacol; 2007; 20(2):401-3. PubMed ID: 17624254
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Multicystic mesothelioma of the testicular tunica vaginalis].
    Rosales Leal JL; Tallada Buñuel M; Espejo Maldonado E; Cózar Olmo JM; Vicente Prados FJ; Martínez Morcillo A; Buitragosivianes S; Rodríguez Herrera F; Ortiz Gorráiz M; Zilbermman Morales S; Chamorro Santos C
    Arch Esp Urol; 2003 Dec; 56(10):1154-7. PubMed ID: 14763424
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.